Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer
Clinical trial NCT04848337 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04848337
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-25
- Primary completion
- 2025-01-08
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.